Board meetings, strategic plans, and buyer signals from Adam Bledsoe’s organization
Apr 28, 2026·BoardMeeting
Board
Institutional Biosafety Committee Meeting Minutes
The committee conducted a continuing review of a Phase 2 study for a GPRC5D-directed CAR T cell therapy. Key discussion topics included the reaffirmation of BSL-2 containment requirements, the oversight period, and a review of facility practices regarding biohazardous waste storage and study agent preparation. The committee formally approved both the research protocol and the site requirements after verifying documentation and site safety procedures.
Sep 26, 2025·BoardMeeting
Board
Institutional Biosafety Committee Meeting Minutes
The committee conducted a continuing review of the Moderna Therapeutics mRNA-4157-P201 protocol for high-risk melanoma. The review included an overview of the protocol and facility practices, with the committee reaffirming BSL-1 containment requirements and the duration of IBC oversight. The committee formally approved both the research protocol and the site requirements.
Jul 15, 2025·StrategicPlan
Board
Northside Hospital, Inc. Community Health Needs Assessment 2025-2027
This Community Health Needs Assessment (CHNA) for Northside Hospital, Inc. outlines its strategic approach for fiscal years 2025-2027, representing the fifth cycle of assessing, prioritizing, and addressing community health needs. The plan identifies nine key health priorities: Cardiovascular, Cancer, Access to Care, Behavioral Health & Substance Use Disorder, Maternal & Infant Health, Diabetes & Obesity, Healthy Lifestyle Behaviors, Respiratory Disease & Smoking, and STIs & HIV/AIDS. Northside Hospital, Inc. commits to addressing these needs through financial assistance, community health improvement services, health professions education, subsidized health services, medical and healthcare research, and strategic contributions to partner organizations, with a particular focus on vulnerable populations and health equity.
Jul 3, 2025·BoardMeeting
Board
Institutional Biosafety Committee Meeting Minutes
The committee conducted a continuing review of a clinical research protocol regarding an expanded access program for gene-modified cells in patients with multiple myeloma. Key discussions included reaffirming the requirement for BSL-2 containment, extending the period of committee oversight, and evaluating facility practices. Recommendations were made regarding the update of standard operating procedures for eye flushing protocols and clarifying PPE disposal container specifications. Both the research protocol and the site requirements were officially approved.
Extracted from official board minutes, strategic plans, and video transcripts.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
